БЛОГ

Archive for the ‘biotech/medical’ category: Page 2441

Aug 25, 2016

Hacking microbes

Posted by in categories: biotech/medical, engineering, food

Biology is the world’s greatest manufacturing platform, according to MIT spinout Ginkgo Bioworks.

The synthetic-biology startup is re-engineering yeast to act as tiny organic “factories” that produce chemicals for the flavor, fragrance, and food industries, with aims of making products more quickly, cheaply, and efficiently than traditional methods.

“We see biology as a transformative technology,” says Ginkgo co-founder Reshma Shetty PhD ’08, who co-invented the technology at MIT. “It is the most powerful and sophisticated manufacturing platform on the planet, able to self-assemble incredible structures at a scale that is far out of reach of the most cutting-edge human technology.”

Read more

Aug 25, 2016

Robotic Brain Training Relieves Paralysis in Duke Study

Posted by in categories: biotech/medical, computing, cyborgs, neuroscience, robotics/AI

Excellent! Super human capabilities at work via brain-controlled robotics.


Eight people who spent years paralyzed from spinal cord injuries have regained partial control of their lower limbs as well as some sensation following work with brain-controlled robotics. Five of the participants had been paralyzed for at least five years and two had been paralyzed for more than ten.

It took seven months of training before most of the subjects saw any changes. After a year, four patients’ sensation and muscle control changed significantly enough that doctors upgraded their diagnoses from complete to partial paralysis.

Continue reading “Robotic Brain Training Relieves Paralysis in Duke Study” »

Aug 25, 2016

Aubrey De Grey — The Need to Dispel Longevity Sticker Shock

Posted by in categories: biotech/medical, life extension

https://www.youtube.com/watch?v=N6eDDIyS_EA

Longevity sticker shock is holding back progress in rejuvenation biotechnology.


Filmed at BIL 2016 in Los Angeles.

Read more

Aug 24, 2016

Climate Study: By 2085 All U.S. Cities Except San Francisco Will Be Too Hot to Host Summer Olympics

Posted by in categories: biotech/medical, health

http://democracynow.org — A new article in the medical journal The Lancet has concluded much of the Northern Hemisphere will be too hot by 2085 to host the Summer Olympics. Researchers are projecting only eight cities in the hemisphere outside of Western Europe would be cool enough to host the Games. This includes just three cities in North America: Calgary, Vancouver and San Francisco. The list of cities where it could be too hot is staggering: Istanbul, Madrid, Rome, Paris, Budapest, Tokyo, New York, Chicago, Los Angeles—and the list goes on. Extreme high temperatures have already impacted the athletic world. In 2007, high heat forced the cancellation of the Chicago Marathon. At this year’s U.S. Olympic marathon trials in Los Angeles, 30 percent of the runners dropped out of the race due to the heat. For more, we speak with Kirk Smith, lead author of the article and professor of global environmental health at the University of California, Berkeley.

Democracy Now! is an independent global news hour that airs weekdays on nearly 1,400 TV and radio stations Monday through Friday. Watch our livestream 8-9AM ET: http://democracynow.org

Continue reading “Climate Study: By 2085 All U.S. Cities Except San Francisco Will Be Too Hot to Host Summer Olympics” »

Aug 24, 2016

What would you say if I told you that aging happens not because of accumulation of stresses, but rather because of the intrinsic properties of the gene network of the organism?

Posted by in categories: biotech/medical, law, life extension, mathematics

I’m guessing you’d be like: surprised .

So, here’s the deal. My biohacker friends led by Peter Fedichev and Sergey Filonov in collaboration with my old friend and the longevity record holder Robert Shmookler Reis published a very cool paper. They proposed a way to quantitatively describe the two types of aging – negligible senescence and normal aging. We all know that some animals just don’t care about time passing by. Their mortality doesn’t increase with age. Such negligibly senescent species include the notorious naked mole rat and a bunch of other critters like certain turtles and clams to name a few. So the paper explains what it is exactly that makes these animals age so slowly – it’s the stability of their gene networks.

What does network stability mean then? Well, it’s actually pretty straightforward – if the DNA repair mechanisms are very efficient and the connectivity of the network is low enough, then this network is stable. So, normally aging species, such as ourselves, have unstable networks. This is a major bummer by all means. But! There is a way to overcome this problem, according to the proposed math model.

Continue reading “What would you say if I told you that aging happens not because of accumulation of stresses, but rather because of the intrinsic properties of the gene network of the organism?” »

Aug 24, 2016

Why De Beers is spending on diamond technology

Posted by in categories: bioengineering, biotech/medical

Fraud detection technology is in high demand and growing thanks to areas such as India. However, there is a huge growing demand for synthetic diamonds in their use in technology, medical, synthetic biology as well.


It takes billions of years to produce a natural diamond, but a laboratory can grow one in days and to the untrained eye they look the same. In an attempt to protect its reputation, De Beers has developed technology that can spot the difference. Ivor Bennett reports.

When dealing with diamonds, one can never be too sure. That’s why at De Beers, it’s not just humans checking the gems anymore, but machines too. SOUNDBITE (English) JONATHAN KENDALL, PRESIDENT, INTERNATIONAL INSTITUTE OF DIAMOND GRADING AND RESEARCH, SAYING: “A synthetic is a man-made product. It’s not a gem, it’s not a beautiful product. It’s not about love and affection and emotion. And it’s not unique and it’s not mysterious. And that’s everything that a diamond is.” It takes about 3 billion years to make a natural diamond. but just three weeks for a synthetic one. To the naked eye though, they look the same. So how do you tell the difference? SOUNDBITE (English) IVOR BENNETT, REUTERS REPORTER, SAYING: “It’s all to do with how the stone looks under UV light. A natural diamond for example will appear dark blue in colour with a regular structure. But if i click on the synthetic one, you can see it’s much lighter with these block-like structures, which is down to its irregular growth.

Continue reading “Why De Beers is spending on diamond technology” »

Aug 24, 2016

“Interscatter” Tech Converts Bluetooth For WiFi-Connected Implants

Posted by in categories: biotech/medical, internet, mobile phones, neuroscience

Nice.


Engineers at the University of Washington (UW) have devised a new method of wireless communication that converts Bluetooth transmission from mobile devices into Wi-Fi signals. Using this “interscatter” communications technology allows medical devices and implants with limited power sources to gain the ability to send data using low-power Wi-Fi signals to smartphones and smartwatches.

The UW team previously described the technique of “backscattering” ambient RF signals — repurposing existing RF signals in the environment — to enable device-to-device communication without the need for onboard power sources. Now, the team builds on that prior research to introduce “interscattering,” the inter-technology, over-the-air conversion of Bluetooth signals to create Wi-Fi transmissions.

Continue reading “‘Interscatter’ Tech Converts Bluetooth For WiFi-Connected Implants” »

Aug 24, 2016

Scientists Develop DNA Analog Circuit Which Performs Mathematical Calculations In A Test Tube

Posted by in categories: biotech/medical, mathematics

Luv it!


There’s quite a lot of other things we don’t know DNA are being used for, like solving math problems for one.

Read more

Aug 24, 2016

Gene editing will challenge ethics at Biological Weapons Convention

Posted by in categories: bioengineering, biotech/medical, ethics, genetics

Anyone attending the Bioweapons Convention in December?


He signatory nations of the Biological Weapons Convention (BWC) will meet …to discuss the state of bioweapons globally…he world has radically changed s.

Read more

Aug 24, 2016

An Interview with Kelsey Moody of Ichor Therapeutics, Bringing a SENS Therapy for Macular Degeneration to the Clinic

Posted by in categories: biotech/medical, life extension

Will Ichor Therapeutics be the first to clinic with a SENS based approach?


As I mentioned last week, earlier this year Fight Aging! invested a modest amount in the Ichor Therapeutics initiative to develop a treatment for macular degeneration, joining a number of other amateur and professional investors in helping to get this venture started. The approach taken here is based on the results of research carried out at the Methuselah Foundation and SENS Research Foundation over much of the past decade, funded by philanthropists and the support of our community of longevity science enthusiasts. This is how we succeed in building the future: medical science in the laboratory leads to medical development in startup companies, each new stage bringing treatments capable of repairing specific forms of age-related molecular damage that much closer to the clinic.

Ichor Therapeutics is one of a growing number of success stories to emerge from the SENS rejuvenation research community. Young scientists, advocates, and donors involved in earlier projects — years ago now — have gone on to build their own ventures, while retaining an interest in stepping up to do something meaningful to help bring an end to aging. Back in 2010, Kelsey Moody worked on the LysoSENS project to find ways to break down damaging metabolic waste in old tissues; fast-forward six years, and he is the now the CEO of a successful small biotechnology company with a great team, taking that very same technology and putting it to good use. I recently had the chance to ask Kelsey a few questions about the future of SENS rejuvenation research, as well as how the Ichor scientists intend to construct a new class of therapy for macular degeneration, one based on removing one of the root causes of the condition.

Continue reading “An Interview with Kelsey Moody of Ichor Therapeutics, Bringing a SENS Therapy for Macular Degeneration to the Clinic” »